medixo centre

Abiraterone 250 mg is the newest drug that has found its use in the treatment of prostate cancer, even in advanced stages. According to official figures, the treatment of cancer patients with such an innovative drug has reduced mortality by 35%, increasing the survival rate for metastatic cancer. It is also important to note that Abiraterone 250 mg is able to minimize pain syndrome. As a rule, Zitiga is used more often in European countries. However, the cost of this drug is simply not affordable for most of the post-Soviet space. Therefore, leading Russian oncologists often recommend that their patients buy Abirapro Abiraterone 250 mg (Zytiga). The action of the drug is that it suppresses the activity of an enzyme necessary for tumor growth. As a result, the production of hormones decreases, both in the adrenal glands and testes, as well as in the tumor. According to oncologists, this drug is a true revolutionary breakthrough in the treatment of cancer. It has proven to be effective e

Medixo Centre is a licensed pharmaceutical wholesaler, exporters, and shippers of best quality Hepatitis, Anti-HIV, Anti-Cancer Pharma Products.